Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
In Vitro Synergy of Echinocandins With Triazoles Against Fluconazole-Resistant Candida Parapsilosis Complex Isolates Publisher Pubmed



Ahmadi A1 ; Mahmoudi S2 ; Rezaie S1 ; Hashemi SJ1 ; Dannaoui E3 ; Badali H4, 5 ; Ghaffari M6 ; Aala F7 ; Izadi A1 ; Maleki A1 ; Meis JF8, 9 ; Khodavaisy S1
Authors

Source: Journal of Global Antimicrobial Resistance Published:2020


Abstract

Introduction: Candida parapsilosis (C. parapsilosis) is a common non-albicans Candida species ranked as the second common cause of bloodstream infections. Azole resistance and elevated echinocandin MICs have been reported for these fungi. This study was conducted to determine the interactions between azoles and echinocandins against C. parapsilosis species complex. Materials and methods: Fifteen fluconazole-resistant clinical isolates of C. parapsilosis complex were included: C. parapsilosis sensu stricto (n = 7), C. orthopsilosis (n = 5) and C. metapsilosis (n = 3). The activity of azoles (fluconazole, itraconazole) and echinocandins (anidulafungin, micafungin) alone and in combination was determined using checkerboard broth microdilution. The results were determined based on the fractional inhibitory concentration index (FICI). Results: In vitro combination of fluconazole with anidulafungin was found to be synergistic (FICI 0.07–0.37) and decreased the MIC range from 4–64 μg/mL to 0.5–16 μg/mL for fluconazole and from 2–8 μg/mL to 0.125–1 μg/mL for anidulafungin. Similarly, interactions of fluconazole with micafungin (FICI 0.25–0.5), itraconazole with anidulafungin (FICI 0.15–0.37) and itraconazole with micafungin (FICI 0.09–0.37) were synergistic. Conclusion: The combination of fluconazole and itraconazole with either anidulafungin or micafungin demonstrated synergistic interactions against C. parapsilosis species complex, especially against isolates with elevated MIC values. However, the use of these combinations in clinical practice and the clinical relevance of in vitro combination results remain unclear. © 2019 International Society for Antimicrobial Chemotherapy
Related Docs
View other Related Docs
1. Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida Parapsilosis Species Complex Blood Isolates, Frontiers in Cellular and Infection Microbiology (2020)
2. Comparative in Vitro Activities of Seven Antifungal Drugs Against Clinical Isolates of Candida Parapsilosis Complex, Journal de Mycologie Medicale (2020)
3. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida Orthopsilosis, and Candida Metapsilosis: An Iranian Multicenter Study (2014–2019), Frontiers in Cellular and Infection Microbiology (2019)
Experts (# of related papers)
View all Related Experts
Sadegh Khodavaisy (13)
Mohammadreza Salehi (8)
Other Related Docs
4. Candidemia Among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of Candida Parapsilosis, Journal of Fungi (2022)
5. Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated From Candidemia, Mycopathologia (2021)
6. Antifungal Susceptibility Pattern and Biofilm-Related Genes Expression in Planktonic and Biofilm Cells of Candida Parapsilosis Species Complex, Current Medical Mycology (2019)
7. Antifungal Susceptibility Analysis of Clinical Isolates of Candida Parapsilosis in Iran, Iranian Journal of Public Health (2016)
8. Clinical, Epidemiological, and Mycological Features of Patients With Candidemia: Experience in Two Tertiary Referral Centers in Iran, Current Medical Mycology (2022)
9. M Eyerozyma Guilliermondii Species Complex: Review of Current Epidemiology, Antifungal Resistance, and Mechanisms, Brazilian Journal of Microbiology (2022)
10. Evaluation of Virulence Factors and Azole Resistance Mechanisms of Candida Tropicalis Isolates From Head and Neck Cancer Patients With Opc, Iranian Journal of Microbiology (2023)
11. The Relationship Between Biofilm Formation and Mortality in Patients With Candida Tropicalis Candidemia, Microbial Pathogenesis (2021)
12. Relationship Between Antifungal Susceptibility Profile and Virulence Factors in Candida Albicanisolated From Nail Specimens, Revista da Sociedade Brasileira de Medicina Tropical (2020)
13. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)
14. Candida Auris, an Emerging Fungal Pathogen, Journal of Mazandaran University of Medical Sciences (2019)
15. Antifungal Susceptibility, Genotyping, Resistance Mechanism, and Clinical Profile of Candida Tropicalis Blood Isolates, Medical Mycology (2020)
16. Indifferent Effect of Nonsteroidal Anti-Inflammatory Drugs (Nsaids) Combined With Fluconazole Against Multidrug-Resistant Candida Auris, Current Medical Mycology (2019)
17. In Vitro Combination of Antifungal Drugs With Tacrolimus (Fk506) Holds Promise Against Clinical Candida Species, Including Candida Auris, Medical Mycology (2023)
18. Identification of Uncommon Oral Yeasts From Cancer Patients by Maldi-Tof Mass Spectrometry, BMC Infectious Diseases (2018)
19. In Vitro Interaction of Geldanamycin With Triazoles and Echinocandins Against Common and Emerging Candida Species, Mycopathologia (2019)
20. Incidence and Spectrum of Yeast Species Isolated From the Oral Cavity of Iranian Patients Suffering From Hematological Malignancies, Journal of Oral Microbiology (2019)